SENSICARDIAC vs Cardiomo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC

by DIACOUSTIC MEDICAL (PTY)

Cardiomo

by Cardiomo, Inc.

AI Verdict

SENSICARDIAC focuses on AI-powered heart murmur detection through electronic stethoscopes, providing diagnostic support for physicians. Cardiomo, conversely, offers continuous remote heart health monitoring via a wearable device, emphasizing early detection of cardiovascular events and real-time alerts for users and caregivers. While both are cardiology AI tools, SENSICARDIAC is geared towards point-of-care diagnostics, whereas Cardiomo is designed for ongoing, passive monitoring.

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your primary need is an AI-powered diagnostic aid for real-time heart murmur classification during clinical auscultation. This tool is ideal for physicians in cardiology, internal medicine, or pediatrics who utilize electronic stethoscopes and require immediate, objective analysis to differentiate between pathological and physiological murmurs, thereby streamlining diagnosis and reducing unnecessary referrals. It excels in providing detailed cardiac reports and guided auscultation within a clinical or telehealth setting.

View SENSICARDIAC →

Choose Cardiomo if…

Choose Cardiomo if your focus is on continuous, long-term remote monitoring of a patient's overall heart health and vital signs outside of a clinical setting. This wearable device and AI platform are best suited for managing patients with known cardiovascular conditions, those at high risk, or elderly individuals requiring ongoing surveillance for arrhythmias, cardiovascular events, and fall detection, with real-time alerts for timely intervention by caregivers or medical professionals.

View Cardiomo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC	Cardiomo
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud, Desktop (Windows)	Cloud-based with wearable device and mobile app
BAA Available	Yes AI-estimated	Unknown
FDA Status	1 AI-estimated	Unknown
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC

SENSICARDIAC offers a more direct and interactive user experience for clinicians, integrating with existing electronic stethoscopes and providing real-time analysis and guided auscultation within a diagnostic workflow. Cardiomo, while offering continuous monitoring via a wearable, has limited direct user interaction with the data for the patient, and its primary usability is for passive monitoring in research settings. SENSICARDIAC's usability was also rated highly in its FDA clearance documentation.

Clinical Value

Cardiomo

Cardiomo demonstrates broader clinical value through its validated ability to continuously monitor multiple physiological parameters (ECG, heart rate, respiration, skin temperature) and detect various conditions like arrhythmias and cardiovascular events. SENSICARDIAC, while valuable for heart murmur detection and classification, has a more specialized clinical application.

Pricing & Value

Tie

Both tools lack publicly available current pricing information, making a direct comparison of their cost-effectiveness impossible. While Cardiomo previously offered a device with a monthly subscription, current details are not available. SENSICARDIAC implies a subscription model with purchasable components.

Enterprise Readiness

SENSICARDIAC

SENSICARDIAC offers both cloud and desktop deployment options, providing greater flexibility for diverse enterprise IT infrastructures and data management preferences. Both tools claim HIPAA compliance and offer BAAs, which are crucial for enterprise adoption. Cardiomo's deployment is cloud-based with a wearable and mobile app.

Innovation

Cardiomo

Cardiomo's innovation lies in its medical-grade wearable patch for continuous, multi-parameter vital sign monitoring and AI-powered disease detection with real-time alerts. SENSICARDIAC is innovative in its AI-powered heart murmur classification and integration with electronic stethoscopes, but Cardiomo's integrated hardware and broader continuous data capture capabilities represent a more comprehensive innovation in remote cardiac monitoring.

Support & Docs

Tie

Neither the provided structured facts nor web searches offered sufficient specific information regarding the depth, accessibility, or quality of support and documentation for either SENSICARDIAC or Cardiomo. Therefore, a definitive winner cannot be determined in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC	Cardiomo
Tool Name	SENSICARDIAC	Cardiomo
Company	DIACOUSTIC MEDICAL (PTY)	Cardiomo, Inc.
Primary Function	AI-powered, cloud-based heart murmur detection service	Medical-grade wearable device and AI platform for continuous remote heart health monitoring
Key Features (Cardiac)	AI-powered heart murmur detection, classification of murmurs (pathological/physiological), detailed cardiac reports, real-time analysis	Continuous vital sign monitoring (ECG, heart rate), AI-powered disease detection (arrhythmias, cardiovascular events), real-time alerts
Integration	Electronic stethoscopes (e.g., 3M Littmannu00ae 3200)	Mobile application (Android and iOS)
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Geriatrics, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC and Cardiomo.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for a cardiologist or primary care physician?

SENSICARDIAC is designed for real-time diagnostic aid during auscultation, integrating with electronic stethoscopes to provide immediate AI-powered murmur classification and downloadable PDF reports for manual EHR integration. Cardiomo, a wearable device for continuous monitoring, provides an up-to-the-minute data dashboard and alerts system for clinicians, which can be integrated into existing platforms via RESTful API, webhooks, and pre-built integrations.

What is the accuracy and sensitivity of each tool in detecting cardiac conditions?

SENSICARDIAC classifies murmurs as dangerous pathological (Class I) or innocent physiological (Class III) by analyzing heart sounds against a large validated database. Cardiomo's medical-grade wearable sensors achieve 99.2% clinical accuracy for R-R interval detection, validated through rigorous clinical studies, and its AI algorithms are trained to detect arrhythmias and other cardiovascular events.

What is the expected learning curve for physicians and the typical time to realize clinical value from each tool?

SENSICARDIAC's guided auscultation process and real-time analysis suggest a relatively low learning curve and immediate clinical value through rapid murmur classification. Cardiomo's mobile application provides user-friendly information, and its continuous monitoring and real-time alerts can offer immediate insights into a patient's heart condition.

Beyond HIPAA, what are the security measures in place to protect patient data for each tool?

Cardiomo has received ISO 13485 certification, an international standard for quality management systems for medical device manufacturers, and adheres to GDPR compliance. SENSICARDIAC's security posture beyond HIPAA is not explicitly detailed in the provided information, but generally, robust security measures for cloud-based health IT applications include encryption, access controls, logging, backups, and incident response.

Are there audit-trail features available in either tool to track user activity and data access?

The provided information does not explicitly detail audit-trail features for SENSICARDIAC. For Cardiomo, while it offers a HIPAA-compliant cloud analytics system, specific audit-trail features are not mentioned. Generally, robust cardiology information systems should include user authentication and event logging to track who accesses patient data and when.

How do these tools support multi-site rollouts and consistent care across different locations?

SENSICARDIAC is a cloud-based service, which inherently supports accessibility from various locations, and it offers user management and billing that can be shared, facilitating multi-site integration. Cardiomo's cloud-based platform and mobile application allow for remote monitoring and data access, which can support consistent care across different sites, though specific multi-site rollout considerations are not detailed.

In what clinical contexts would each tool be most beneficial for a physician?

SENSICARDIAC is most beneficial for physicians in primary care, internal medicine, and pediatrics during routine physical examinations, sports physicals, or urgent care settings to quickly classify heart murmurs and reduce unnecessary referrals. Cardiomo is particularly useful for continuous and remote heart health monitoring in cardiology, geriatrics, and internal medicine, especially for detecting arrhythmias, cardiovascular events, and providing alerts for patients with high cardiovascular disease risk or those requiring long-term monitoring.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring SENSICARDIAC or Cardiomo

Backers

Who funded each tool's parent company.

Cardiomo

Kamet Ventures